Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C

Fox Chase/ Temple Cancer Center, Philadelphia

Inova Fairfax Hospital, Annandale

Metropolitan Research, Fairfax

McGuire VA Medical Center, Richmond

Shands Hospital University of Florida, Gainesville

Clarian Hospital, Indianapolis

Alamo Medical Research, San Antonio

Call For Information, Phoenix

Cedars-Sinai Medical Center, Los Angeles

Stanford University Liver Research, Palo Alto

Call For Information, San Francisco

University of Colorado Hospital, Denver

South Denver Gastroenterology, Englewood

Call for Information, Miami

University of Chicago Medical Center, Chicago

Gulf Coast Research Associates, Baton Rouge

Call For Information, Baltimore

Beth Israel Deaconess Medical Center, Boston

Call for Information, Boston

Call For Information, Worcester

Henry Ford Health System, Detroit

Call For Information, Rochester

Saint Louis University, St Louis

University of New Mexico, Albuquerque

Call For Information, Manhasset

Call for Information, New York

Columbia University Medical Center, New York

Call For Information, Chapel Hill

Call For Information, Durham

University of Cincinnati College of Medicine, Cincinnati

University of Pennsylvania Hospital, Philadelphia

Baylor University Medical Center, Dallas

Methodist Hospital of Dallas, Dallas

University of Texas Southwestern Medical Center at Dallas, Dallas

University of Virginia Health System, Charlotteville

Froedtert Memorial Lutheran Hospital, Milwaukee

Fundacion de Investigacion de Diego, Santurce